Morepen Laboratories Limited - Company Profile

It is a pharma public limited company based in Himachal Pradesh, Himachal Pradesh, India, established in 1984.
1984 Himachal Pradesh, Himachal Pradesh, India Active
Last Updated:
Access Report
About Morepen Laboratories Limited

Morepen Laboratories Limited, a active public limited company, was established on 01 December 1984 in Himachal Pradesh, Himachal Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24231HP1984PLC006028. Registered under ROC Roc Himachal Pradesh. it is listed on BSE: 500288 and NSE: MOREPENLAB. It has an authorized capital of ₹250.00 Cr and a paid-up capital of ₹109.58 Cr.

Formerly known as Morepen Laboratories Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹1,550.16 Cr and a net worth of ₹889.02 Cr. Employing 557 professional, Its leadership includes Savita (Director), Praveen Dutt Kumar (Director), Vipul Kumar Srivastava (Company Secretary). Past directors included Archana Bhargava, Savita, Praveen Dutt Kumar. It holds ₹159.26 Cr open charges and ₹2,545.17 Cr settled loans. Its latest AGM occurred on 06 September 2025, with the balance sheet filed on 31 March 2025. It is based at Village Morepen Nalagarh Road Near Baddi Distt Solan, Himachal Pradesh, Himachal Pradesh, 173205.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24231HP1984PLC006028

  • Registration Number

    006028

  • Incorporation Date

    01 December 1984

  • Authorized Capital

    ₹250.00 Cr

  • Paid-Up Capital

    ₹109.58 Cr

  • ROC Code

    Roc Himachal Pradesh

  • Listing Status

    Listed (BSE: 500288, NSE: MOREPENLAB)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 250.00 Cr
  • Paid Up Capital ₹ 109.58 Cr
  • Company Age 41 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 159.26 Cr
  • Satisfied Charges ₹ 2,545.17 Cr
  • Revenue Growth **** 15.28%
  • Profit Growth **** 139.88%
  • Ebitda **** 109.42%
  • Net Worth 13.96%
  • Total Assets **** 15.72%
Company report

Morepen Laboratories Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Morepen Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Morepen Laboratories Limited?
Current Directors
Name Designation Appointment Date Status
Savita Director 22 Jun 2020 Current
Praveen Dutt Kumar Director 13 Aug 2019 Current
Vipul Kumar Srivastava Company Secretary 12 Nov 2018 Current
Sushil Suri Managing Director 20 Oct 2015 Current
Sharad Jain Director 27 Aug 2024 Current
Ajay Kumar Sharma Nodal Officer 29 Dec 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 23 Sep 2016 Past
Pramod Abcsdd Additional Director 30 Sep 2020 Past
Pramod Abcsdd Additional Director 13 Sep 2019 Past
Pramod Abcsdd Additional Director 27 Sep 2024 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 18 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Morepen Laboratories.

Morepen Laboratories Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 15.28% increase. The company also saw a substantial improvement in profitability, with a 139.88% increase in profit. The company's net worth Soared by an impressive increase of 13.96%.

Morepen Laboratories revenue growth over time
Morepen Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 15.28%
*******
*******
*******
*******
Revenue from Operations
*******
 14.84%
*******
*******
*******
*******
Total Assets
*******
 15.72%
*******
*******
*******
*******
Profit or Loss
*******
 139.88%
*******
*******
*******
*******
Net Worth
*******
 13.96%
*******
*******
*******
*******
EBITDA
*******
 109.42%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Morepen Laboratories?

In 2024, Morepen Laboratories had a promoter holding of 38.22% and a public holding of 61.77%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,592,579,000.00

Satisfied Charges

₹25,451,722,948.00

Charges Breakdown by Lending Institutions
  • Others : 159.26 Cr
Latest Charge Details
Date Lender Amount Status
23 May 2025 Others ₹50.00 Cr Open
22 Apr 2025 Others ₹5.65 M Open
29 Mar 2025 Others ₹2.84 M Open
11 Mar 2025 Others ₹0.97 M Open
21 Jan 2025 Others ₹4.77 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Morepen Laboratories?

Morepen Laboratories has a workforce of 557 employees as of Apr 07, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Morepen Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morepen Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Morepen Laboratories
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Morepen Laboratories Limited last Annual general meeting of members was held on 06 Sep 2025 as per latest MCA records. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 50.00 Cr with Charge ID 101108793 was registered on 23 May 2025. was documented.

  • Charges

    The activity A charge registered on 26 Apr 2022 via Charge ID 100572633 with Others was fully satisfied on 21 May 2025. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.57 Cr with Charge ID 101093377 was registered on 22 Apr 2025. was documented.

  • Balance Sheet

    Morepen Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 0.28 Cr with Charge ID 101077422 was registered on 29 Mar 2025. was completed.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Morepen Laboratories Limited?

The CIN of Morepen Laboratories Limited is L24231HP1984PLC006028.

Where is Morepen Laboratories Limited headquartered?

Morepen Laboratories Limited is headquartered at Village Morepen Nalagarh Road Near Baddi Distt Solan, Himachal Pradesh, Himachal Pradesh, 173205.

When was Morepen Laboratories Limited incorporated?

Morepen Laboratories Limited was incorporated on 01 December 1984.

Who are the current directors of Morepen Laboratories Limited?

The current directors of Morepen Laboratories Limited are

What is the primary industry of Morepen Laboratories Limited?

The primary industry of Morepen Laboratories Limited is Manufacturing.

Is Morepen Laboratories Limited a listed company?

Morepen Laboratories Limited is listed. It is listed on BSE: 500288 and NSE: MOREPENLAB.

What is the capital structure of Morepen Laboratories Limited?

The authorized capital of Morepen Laboratories Limited is ₹250.00 Cr, and the paid-up capital is ₹109.58 Cr.

What is the compliance status of Morepen Laboratories Limited?

The compliance status of Morepen Laboratories Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available